Compared with bronchodilator-only relievers ... All included trials of fast-onset, long-acting beta-agonists (alone or combined with an ICS) as a reliever therapy evaluated formoterol.

This study highlights the benefits of anti-inflammatory inhalers in asthma management, showing reduced complications and ...

Wockhardt Limited, the global pharmaceutical company, has submitted its indigenously developed fast-acting insulin analog, ASPARAPID, for regulatory approval with India’s Drugs Controller ...

A NEW multicenter study, TOReTO, has shown that dual bronchodilator therapy can help reduce exacerbations in patients with chronic obstructive pulmonary disease (COPD), with notable differences in ...

We therefore performed a randomized, double-blind, placebo-controlled trial to determine whether use of a short-acting bronchodilator provides a protective effect in patients with COPD undergoing ...

When used for this purpose, clenbuterol is considered a long-acting bronchodilator with a drug half-life of up to 48 hours. In the United States, clenbuterol is not approved for use in humans and is ...

Formoterol (brand names Perforomist, Foradil) is a bronchodilator in a class of medications called long-acting beta agonists (LABAs). It is used to control wheezing, shortness of breath, coughing and ...

The sharp movement in the early deals was seen after the company announced that it had filed its fast-acting insulin analog, Aspart injection (ASPARAPID), with the Drug Controller General of India.

The fast in “fast fashion” refers to the speed with which clothing products are manufactured and put on the market for consumers. This rapid production of clothing has led to some brands ...